BCL2L12 Antibody (N-term) Blocking Peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q9HB09 |
---|---|
Clone Names | 110826043 |
Gene ID | 83596 |
---|---|
Other Names | Bcl-2-like protein 12, Bcl2-L-12, Bcl-2-related proline-rich protein, BCL2L12, BPR |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | BCL2L12 |
---|---|
Synonyms | BPR |
Tissue Location | Expressed mainly in breast, thymus, prostate, fetal liver, colon, placenta, pancreas, small intestine, spinal cord, kidney, and bone marrow and to a lesser extent in many other tissues. Isoform 2 is primarily expressed in skeletal muscle |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
The protein encoded by this gene belongs to the BCL-2protein family. BCL-2 family members form hetero- or homodimers andact as anti- or pro-apoptotic regulators that are involved in awide variety of cellular activities. This protein contains a Bcl-2homology domain 2 (BH2). The function of this gene has not yet beendetermined. Two alternatively spliced transcript variants of thisgene encoding distinct isoforms have been reported. [provided byRefSeq].
References
Bailey, S.D., et al. Diabetes Care 33(10):2250-2253(2010)Florou, D., et al. Biochem. Biophys. Res. Commun. 391(1):214-218(2010)Hong, Y., et al. Mol. Cell. Biochem. 333 (1-2), 323-330 (2010) :Talmud, P.J., et al. Am. J. Hum. Genet. 85(5):628-642(2009)Thomadaki, H., et al. Ann. N. Y. Acad. Sci. 1171, 276-283 (2009) :
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.